History of medullary thyroid carcinoma MEN2 syndrome Severe pancreatitis history Severe gastroparesis Pregnancy or breastfeeding A full medical evaluation is required before prescription
While the researchers in this study utilized pre-existing data available to them and did not directly measure alcohol or opioid use, they found clinically meaningful associations between semaglutide/tirzepatide-type weight loss medication prescription and reductions in alcohol intoxication and opioid poisoning events in patients at risk for these deleterious health outcomes
B12 and L-carnitine support energy production
If you stop taking Wegovy, the medication will gradually leave your system over 57 weeks, and you may regain weight or see a return of metabolic conditions
doi:10.1152/ajpheart.00574.2023 Holman RR, Bethel MA, Mentz RJ, et al
Patels approach involves personalized assessments that help identify which patients might benefit from GLP-1 weight loss injections and how Semaglutide injection for weight loss can be safely integrated into their care